Albert Bourla, Pfizer CEO (Photographer: Michael Nagle/Bloomberg via Getty Images)
December 12, 2023 07:27 AM ESTUpdated 09:10 AM
Deals
Pharma

Pfiz­er to com­plete Seagen ac­qui­si­tion Thurs­day, An­gela Hwang to de­part amid ex­ec­u­tive shuf­fle

Kyle LaHucik

Senior Reporter

Pfiz­er said Tues­day morn­ing it ex­pects to seal its $43 bil­lion Seagen ac­qui­si­tion on Thurs­day af­ter hav­ing cleared …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump names Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA; al­so names CDC, Sur­geon Gen­er­al picks

FDA ap­proves Bridge­Bio's heart dis­ease drug, set­ting up com­pe­ti­tion with Pfiz­er, Al­ny­lam

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

Sur­round­ed by AI bio gi­ants, tiny start­up Nabla Bio makes de no­vo an­ti­bod­ies look more like drugs 

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times